These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36592307)
21. The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs. Bueno C; Montes R; Menendez P Stem Cell Rev Rep; 2010 Jun; 6(2):215-23. PubMed ID: 20180051 [TBL] [Abstract][Full Text] [Related]
22. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Yu X; Alder JK; Chun JH; Friedman AD; Heimfeld S; Cheng L; Civin CI Stem Cells; 2006 Apr; 24(4):876-88. PubMed ID: 16513761 [TBL] [Abstract][Full Text] [Related]
23. Ex Vivo Expansion of CD34 Bari S; Zhong Q; Fan X; Poon Z; Lim AST; Lim TH; Dighe N; Li S; Chiu GNC; Chai CLL; Hwang WYK Stem Cells Transl Med; 2018 May; 7(5):376-393. PubMed ID: 29392885 [TBL] [Abstract][Full Text] [Related]
24. Fucosyltransferase VII improves the function of selectin ligands on cord blood hematopoietic stem cells. Wan X; Sato H; Miyaji H; McDaniel JM; Wang Y; Kaneko E; Gibson B; Mehta-D'Souza P; Chen Y; Dozmorov M; Miller LP; Goodman J; Sun Z; Xia L Glycobiology; 2013 Oct; 23(10):1184-91. PubMed ID: 23899669 [TBL] [Abstract][Full Text] [Related]
26. Human genome-edited hematopoietic stem cells phenotypically correct Mucopolysaccharidosis type I. Gomez-Ospina N; Scharenberg SG; Mostrel N; Bak RO; Mantri S; Quadros RM; Gurumurthy CB; Lee C; Bao G; Suarez CJ; Khan S; Sawamoto K; Tomatsu S; Raj N; Attardi LD; Aurelian L; Porteus MH Nat Commun; 2019 Sep; 10(1):4045. PubMed ID: 31492863 [TBL] [Abstract][Full Text] [Related]
27. A sticky wicket: Defining molecular functions for CD34 in hematopoietic cells. Hughes MR; Canals Hernaez D; Cait J; Refaeli I; Lo BC; Roskelley CD; McNagny KM Exp Hematol; 2020 Jun; 86():1-14. PubMed ID: 32422232 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological inhibition of AKT activity in human CD34 Chen S; Gao R; Kobayashi M; Yu H; Yao C; Kapur R; Yoder MC; Liu Y Exp Hematol; 2017 Jan; 45():74-84. PubMed ID: 27645691 [TBL] [Abstract][Full Text] [Related]
29. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Janowska-Wieczorek A; Majka M; Kijowski J; Baj-Krzyworzeka M; Reca R; Turner AR; Ratajczak J; Emerson SG; Kowalska MA; Ratajczak MZ Blood; 2001 Nov; 98(10):3143-9. PubMed ID: 11698303 [TBL] [Abstract][Full Text] [Related]
30. Gene Editing in Hematopoietic Stem Cells. Liao J; Wu Y Adv Exp Med Biol; 2023; 1442():177-199. PubMed ID: 38228965 [TBL] [Abstract][Full Text] [Related]
31. Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells. Lee BC; Lozano RJ; Dunbar CE Mol Ther; 2021 Nov; 29(11):3205-3218. PubMed ID: 34509667 [TBL] [Abstract][Full Text] [Related]
32. Zebrafish In-Vivo Screening for Compounds Amplifying Hematopoietic Stem and Progenitor Cells: - Preclinical Validation in Human CD34+ Stem and Progenitor Cells. Arulmozhivarman G; Kräter M; Wobus M; Friedrichs J; Bejestani EP; Müller K; Lambert K; Alexopoulou D; Dahl A; Stöter M; Bickle M; Shayegi N; Hampe J; Stölzel F; Brand M; von Bonin M; Bornhäuser M Sci Rep; 2017 Sep; 7(1):12084. PubMed ID: 28935977 [TBL] [Abstract][Full Text] [Related]
33. Long-term multilineage engraftment of autologous genome-edited hematopoietic stem cells in nonhuman primates. Peterson CW; Wang J; Norman KK; Norgaard ZK; Humbert O; Tse CK; Yan JJ; Trimble RG; Shivak DA; Rebar EJ; Gregory PD; Holmes MC; Kiem HP Blood; 2016 May; 127(20):2416-26. PubMed ID: 26980728 [TBL] [Abstract][Full Text] [Related]
34. Extracellular vesicles from human iPSCs enhance reconstitution capacity of cord blood-derived hematopoietic stem and progenitor cells. Karnas E; Sekuła-Stryjewska M; Kmiotek-Wasylewska K; Bobis-Wozowicz S; Ryszawy D; Sarna M; Madeja Z; Zuba-Surma EK Leukemia; 2021 Oct; 35(10):2964-2977. PubMed ID: 34140648 [TBL] [Abstract][Full Text] [Related]
35. Alpha Lipoic-Acid Potentiates Ex Vivo Expansion of Human Steady-State Peripheral Blood Hematopoietic Primitive Cells. Debeissat C; Avalon M; Huart M; Duchez P; Rodriguez L; Vlaski-Lafarge M; Ivanovic Z; Brunet de la Grange P Biomolecules; 2022 Mar; 12(3):. PubMed ID: 35327623 [TBL] [Abstract][Full Text] [Related]
36. Non-fucosylated CB CD34 Robinson SN; Thomas MW; Simmons PJ; Lu J; Yang H; Javni JA; Shpall EJ; Zweidler-Mckay PA Cytotherapy; 2017 Feb; 19(2):285-292. PubMed ID: 27919572 [TBL] [Abstract][Full Text] [Related]
37. Ex vivo editing of human hematopoietic stem cells for erythroid expression of therapeutic proteins. Pavani G; Laurent M; Fabiano A; Cantelli E; Sakkal A; Corre G; Lenting PJ; Concordet JP; Toueille M; Miccio A; Amendola M Nat Commun; 2020 Jul; 11(1):3778. PubMed ID: 32728076 [TBL] [Abstract][Full Text] [Related]
38. Wharton's jelly mesenchymal stem cell-based or umbilical vein endothelial cell-based serum-free coculture with cytokines supports the ex vivo expansion/maintenance of cord blood hematopoietic stem/progenitor cells. Li Q; Zhao D; Chen Q; Luo M; Huang J; Yang C; Wang F; Li W; Liu T Stem Cell Res Ther; 2019 Dec; 10(1):376. PubMed ID: 31806004 [TBL] [Abstract][Full Text] [Related]
39. Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells. Du Z; Wang Z; Zhang W; Cai H; Tan WS Cell Prolif; 2015 Jun; 48(3):293-300. PubMed ID: 25899394 [TBL] [Abstract][Full Text] [Related]
40. Differential gene expression underlying the functional distinctions of primary human CD34+ hematopoietic stem and progenitor cells from peripheral blood and bone marrow. Steidl U; Kronenwett R; Haas R Ann N Y Acad Sci; 2003 May; 996():89-100. PubMed ID: 12799287 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]